Ceryvyn Therapeutics (ASX:CYV) NonCurrent Deferred Liabilities: A$0.00 Mil (As of Jun. 2025)


What is Ceryvyn Therapeutics NonCurrent Deferred Liabilities?

Ceryvyn Therapeutics ASX:CYV -7.69% NonCurrent Deferred Liabilities is A$0.00 Mil as of Jun. 2025. The stock has 3 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Ceryvyn Therapeutics's non-current deferred liabilities for the quarter that ended in Jun. 2025 was A$0.00 Mil.

Ceryvyn Therapeutics NonCurrent Deferred Liabilities Related Terms

Ceryvyn Therapeutics NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Ceryvyn Therapeutics's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ceryvyn Therapeutics NonCurrent Deferred Liabilities Chart

Ceryvyn Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ceryvyn Therapeutics Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a NonCurrent Deferred Liabilities of A$0.00 Mil mean?
Ceryvyn Therapeutics (ASX:CYV) has a NonCurrent Deferred Liabilities of A$0.00 Mil as of Jun. 2025. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Ceryvyn Therapeutics and its competitors.
Is Ceryvyn Therapeutics' NonCurrent Deferred Liabilities too high?
Ceryvyn Therapeutics' current NonCurrent Deferred Liabilities is A$0.00 Mil.
How does Ceryvyn Therapeutics' NonCurrent Deferred Liabilities compare to VRTX and REGN?
Ceryvyn Therapeutics' NonCurrent Deferred Liabilities of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Ceryvyn Therapeutics and its competitors. Ceryvyn Therapeutics's current NonCurrent Deferred Liabilities is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ceryvyn Therapeutics stock overvalued right now?
Ceryvyn Therapeutics (ASX:CYV) has a current NonCurrent Deferred Liabilities of A$0.00 Mil. The current NonCurrent Deferred Liabilities is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Ceryvyn Therapeutics (ASX:CYV), the current NonCurrent Deferred Liabilities is A$0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ceryvyn Therapeutics Business Description

Address C/ Prime Company Compliance, 505 Little Collins Street, Level 9, Melbourne, VIC, AUS, 3000
Opthea Ltd is engaged in researching and developing novel therapeutic products that target Vascular Endothelial Growth Factors (VEGF) C, D, and R3. The Group operates in one industry and two geographical areas, namely biotechnology and healthcare, with operations in Australia and the United States. The company focuses on developing biological therapeutics for eye diseases and is currently developing a novel biologic therapy, OPT-302, for the treatment of eye conditions. Its products are based on an intellectual property portfolio covering VEGF-C, VEGF-D, and VEGF Receptor-3 targets, aimed at treating diseases associated with blood and lymphatic vessel growth and vascular leakage.